Life · Medicine · Pharma · Stocks

CLINICAL TRIALS : COVID-19

Phase 3 trials of Favipiravir by Glenmark shows faster time to improvement in mid to moderate COVID19 patients

Claim is “no serious adverse effects seen” which is positive


Discover more from ALPHA AFFAIRS

Subscribe to get the latest posts sent to your email.